MIMEDX to Participate at Upcoming Investor Conferences

Rhea-AI Summary

Marietta, Ga., May 5, 2022 - MiMedx Group (Nasdaq: MDXG) announced participation in two upcoming investor conferences. The Bank of America Securities 2022 Healthcare Conference will feature a fireside chat on May 10 at 12:15 PM PT / 3:15 PM ET, accessible via webcast. The H.C. Wainwright Global Investment Conference will occur on May 24 at 10:00 AM ET, also available via webcast.

MARIETTA, Ga., May 05, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that senior management will participate in the following investor conferences:

• Bank of America Securities 2022 Healthcare Conference
  Fireside Chat: Tuesday, May 10, 2022 at 12:15 PM PT / 3:15 PM ET
  Webcast: Click here to access

• H.C. Wainwright Global Investment Conference
  Fireside Chat: Tuesday, May 24, 2022 at 10:00 AM ET
  Webcast: Click here to access

Institutional investors interested in meeting with senior management may contact their respective Bank of America or H.C. Wainwright representative.

A live webcast of both fireside chats will be available on the Events page of the Investors section of the Company’s website at www.mimedx.com or through the conference site by using the links above. A replay will be available on the Company’s website following the event.

About MIMEDX
MIMEDX is a transformational placental biologics company, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental tissue engineering, we have both a commercial business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. We derive our products from human placental tissues and process these tissues using our proprietary methods, including the PURION^® process. We employ Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce our allografts. MIMEDX has supplied over two million allografts, through both direct and consignment shipments. For additional information, please visit www.mimedx.com.

Contact:
Jack Howarth
Investor Relations
404-360-5681
jhowarth@mimedx.com

Contact:
Hilary Dixon
Corporate & Strategic Communications
404-323-4779
hdixon@mimedx.com

 

FAQ

What is MiMedx Group's stock symbol?

MiMedx Group is traded under the stock symbol MDXG.

When is the Bank of America Securities 2022 Healthcare Conference for MiMedx?

MiMedx will participate in the Bank of America Securities 2022 Healthcare Conference on May 10, 2022, at 12:15 PM PT / 3:15 PM ET.

How can I access the MiMedx fireside chat on May 10, 2022?

The fireside chat on May 10, 2022, can be accessed via the webcast link provided in the press release.

What date is the H.C. Wainwright Global Investment Conference for MiMedx?

MiMedx's fireside chat at the H.C. Wainwright Global Investment Conference is scheduled for May 24, 2022, at 10:00 AM ET.

Where can I find more information about MiMedx Group?

More information about MiMedx Group can be found on their official website at www.mimedx.com.